K131892

Substantially Equivalent

EV1000 CLINICAL PLATFORM

Applicant: Edwards Lifesciences, LLC
Product code: DXG
Advisory panel: Cardiovascular
Date received: 2013-06-25
Decision date: 2014-05-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.